¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : ½ºÀ§½º ±×·£µå È£ÅÚ ÄÁº¥¼Ç ¼¾ÅÍ

±³À°ÁÖÁ¦ : 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺÎÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ¹Ú¹Î¿µ
¿¬¶ôó : 02-318-5416  

À̸ÞÀÏ : khrs10@k-hrs.org

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 100,000¿ø  

ºñ°í »çÀüµî·Ï ½Ã : Àü¹®ÀÇ(±³¼ö, °³¿øÀÇ, ºÀÁ÷ÀÇ) - 10¸¸¿ø / ÀüÀÓÀÇ - 7¸¸¿ø / Àü°øÀÇ, ±ºÀÇ°ü, °£È£»ç, ¹æ»ç¼±»ç, ÀÓ»óº´¸®»ç, ÀÇ·á±â±â ¹× Á¦¾àȸ»ç Á¾»çÀÚ - 5¸¸¿ø / ¿¬±¸¿ø - 3¸¸¿ø / Çлý, ¿Ü±¹ÀÎ(Physician, Scientist), 65¼¼ ÀÌ»ó Àü¹®ÀÇ(±³¼ö, °³¿øÀÇ, ºÀÁ÷ÀÇ) - µî·Ïºñ ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 08:45~09:05 Cryoballoon ablation for AF in Korea: complications and outcomes from a multicenter registry ¾çÇʼº(Â÷ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:05~09:25 Predictors of failure to maintain sinus rhythm after RF catheter ablation of AF ±è´ëÈÆ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:25~09:45 Catheter ablation of AF in patients with heart failure Ming-long Chen(The First Affiliated Hospital of Nanjing Medical University)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:45~10:05 Cryoballoon ablation for longstanding persistent AF ÀÌ»óÈñ(Æ÷Ç× ¼¼¸í±âµ¶º´¿ø)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:05~10:25 Initial experiences of PFA for AF in Singapore Pipin Kojodjojo(ASIAN HEART & VASCULAR CENTRE)

ÈÞ½Ä 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:25~10:30 Break ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:30~10:50 Oral anticoagulation for stroke prevention, warfarin to Factor XI inhibitor Á¤·¡¿µ(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:50~11:10 Symptom scales of AF currently in use, is it suitable? ÃÖÁøÈñ(¾ç»êºÎ»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:10~11:30 Can early rhythm control therapy prevent the AF progression? ÀÌ´ëÀÎ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:30~11:50 How to treat tachycardia induced CMP? Rhythm vs Rate (including AVN ablation) °ûÇýºó(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:50~12:10 Lifestyle and Risk factor modification for reduction of atrial fibrillation - recommendation for physical activity Wei-Chung Tsai (Kaohsiung Medical University)

½Ä»ç 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 12:10~13:20 Lunch ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 13:20~13:40 Unmet need for new energy source (complications of thermal ablation) ½ÉÀç¹Î(°í·ÁÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 13:40~14:00 Clinical data of PFA (catheter configuration / energy delivery method / successful PVI rate / recurrence rate / procedural time) Kyoung-Ryul Julian Chun(CCB Frankfurt)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:00~14:20 Ischemic stroke after PFA (thrombotic or air embolic / accidental LAA electrical isolation) ±è¹®Çö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:20~14:40 Collateral damage after PFA (phrenic nerve / coronary artery / esophagus) À̱¤³ë(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:40~15:00 My experience on pulse field ablation for atrial fibrillation Boris Schmidt(Cardiologisches Centrum Bethanien)

ÈÞ½Ä 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:00~15:05 Break ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:05~15:25 Ablation in ARVC Fa-Po Chung(Taipei Veterans General Hospital)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:25~15:45 Epicardial Ablation in Brugada Syndrome ¹Ú¿¹¹Î(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:45~16:05 Ablation for Papillary Muscle VT Á¶¹Î¼ö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 16:05~16:25 Ablation for ischemic VT Â÷¸íÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 16:25~16:45 Ablation for LV summit VA Yenn-Jiang Lin(Taipei Veterans General Hospital)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦3ȸ ´«¿°Áõ ¿µ»ó°¶·¯¸® : 2023-12-02
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÀÓ»óÅëÁõÇÐȸ ¿Â¶óÀÎ 2023³â ¸®ºäÄÚ½º : 2023-12-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
206 ¼­¿ï °í·Á´ëÇб³¾È¾Ïº´¿ø ÀÏÂ÷ ÀÇ·áÁø°ú ÇÔ²²ÇÏ´Â ½É¹æ¼¼µ¿ÀÇ Ä¡·á : 2018-09-07 0 556 2018-07-28
205 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] ÀÇ·á»ç°í¿Í Á¶Á¤ ÁßÀç / ¼³¸íÀǹ« : 2018-09-06 0 413 2018-07-28
204 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/06 : 2018-09-06 0 377 2018-07-28
203 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-06 0 540 2018-07-28
202 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø 2018 ¾à¹°ÀÌ»ó¹ÝÀÀ ½ÉÆ÷Áö¾ö : 2018-09-05 0 963 2018-07-28
201 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-05 0 649 2018-07-28
200 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø »ç½Ã Áø·áÀÇ ÇÔÁ¤À» ÇÇÇØ°¡·Á¸é : 2018-09-04 0 1,077 2018-07-28
199 ¼­¿ï Á¦ÀϺ´¿ø 2018 »ý½Ä¹ß»ýµ¶¼º¿¬±¸ ¹× ¸¶´õ¸®½ºÅ©ÇÁ·Î±×·¥ÀÇ ÃֽŰæÇâ : 2018-09-02 0 737 2018-07-28
198 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-02 0 928 2018-07-28
197 ¼­¿ï ´ëÇѺñ¸¸°Ç°­ÇÐȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-02 0 981 2018-07-28
196 ¼­¿ï Á¦3ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ¼¾ÅÍ °³¿øÀÇ ¿¬¼ö°­Á -¿°Áõ¼ºÀåÁúȯ Áø·áÀÇ ÃֽŠµ¿Çâ - : 2018-09-02 0 1,508 2018-07-28
195 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø ÀÏÂ÷Áø·á¿¡¼­ ÈçÈ÷ º¸´Â ·ù¸¶Æ¼½ºÁúȯÀÇ °¨º°Áø´Ü ¹× Ä¡·á ¹Ù·Î ¾Ë±â : 2018-09-02 0 939 2018-07-28
194 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇÐȸ Ã߰迬¼ö°­Á : 2018-09-02 0 392 2018-07-28
193 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾È°úÁúȯÀÇ ÃÖ½ÅÁö°ß : 2018-09-02 0 2,311 2018-07-28
192 ¼­¿ï Á¦21ȸ ¼­¿ï¾Æ»êº´¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-02 0 787 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷